Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.

The Prostate - 15 Feb 2013

Kani Kian, Malihi Paymaneh D, Jiang Yuqiu, Wang Haiying, Wang Yixin, Ruderman Daniel L, Agus David B, Mallick Parag, Gross Mitchell E

Abstract excerpt

BACKGROUND: Anterior gradient 2 (AGR2) is associated with metastatic progression in prostate cancer cells as well as other normal and malignant tissues. We investigated AGR2 expression in patients with metastatic prostate cancer. METHODS: Blood was collected from 44 patients with metastatic prostate cancer separated as: castration sensitive prostate cancer (CSPC, n = 5); castration resistant prostate cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromogranin A
Share to Mucoproteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Metastasis

Share to Neoplastic Cells, Circulating

Share to Neuroendocrine Tumors

Share to Oncogene Proteins

Share to Phosphopyruvate Hydratase

Share to Prostate-Specific Antigen

Source

Identifiers

PMID: 22911164
DOI: 10.1002/pros.22569

Genes

AGR2
CGA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.PMID 22911164Read ↗

Prostate cancer cell phenotypes based on AGR2 and CD10 expression.Semantic proximity Read ↗

Overexpression of oncogenic spliced-AGR2vH potentiates cholangiocarcinoma cell tumorigenicity with proteomic alterationsSemantic proximity Read ↗

Functional characterization of three novel candidate biomarkers and therapeutic targets for prostate cancerSemantic proximity Read ↗

Leveraging the Role of the Metastatic Associated Protein Anterior Gradient Homologue 2 in Unfolded Protein Degradation: A Novel Therapeutic Biomarker for CancerSemantic proximity Read ↗

Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2)Semantic proximity Read ↗

ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype.Semantic proximity Read ↗

Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance.Semantic proximity Read ↗

AGR2, a potential prognostic and predictive biomarker and therapeutic to overcome drug resistance in HER2-overexpressing cancerSemantic proximity Read ↗

Molecular Characterization of a Metastatic Neuroendocrine Cell Cancer Arising in the Prostates of Transgenic MiceSemantic proximity Read ↗

Androgen-repressed phenotype in human prostate cancer.Semantic proximity Read ↗

Evaluation of the Adenocarcinoma-Associated Gene AGR2 and the Intestinal Stem Cell Marker LGR5 as Biomarkers in Colorectal CancerSemantic proximity Read ↗

An aberrantly spliced isoform of anterior gradient-2, AGR2vH promotes migration and invasion of cholangiocarcinoma cellSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.